サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1321420

動物用静注液の市場規模、シェア、動向分析レポート：製品別、動物タイプ別、適応症別、最終用途別、地域別、セグメント予測、2023年～2030年

Veterinary Intravenous (IV) Solutions Market Size, Share & Trends Analysis Report By Product, By Animal Type (Companion Animals, Production Animals), By Indication, By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
動物用静注液の市場規模、シェア、動向分析レポート：製品別、動物タイプ別、適応症別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年07月21日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物用静注液市場の成長と動向

Grand View Research, Incの最新レポートによると、世界の動物用静注液の市場規模は、2023年から2030年にかけてCAGR 8.37％で拡大し、2030年には26億7,000万米ドルに達すると予測されています。

この成長の原動力は、動物福祉に対する意識の高まり、動物医療の進歩、ペット飼育の増加、炭疽、膵炎、口内炎などの疾病の流行増加です。動物医療の進歩により、動物が利用できる治療の選択肢は広がっています。動物病院や診療所には、点滴システムなどの高度な診断・治療設備が整っており、これが市場の成長に寄与しています。

動物用として特別に設計された高度な輸液システムの開発により、投与プロセスがより効率的で正確かつ安全になりました。特殊な輸液ポンプや輸液モニタリングシステムなどのこうした技術的進歩は、患者ケアを強化し、合併症のリスクを低減することで、動物用静注液産業にプラスの影響を与えています。多くの地域で可処分所得水準が上昇しているため、ペットの医療への支出が増加しています。ペットの飼い主は、輸液療法を含む質の高い獣医療への投資をより厭わなくなり、市場の成長に寄与しています。

COVID-19後の動物用静注液業界への影響は、世界情勢が進化を続けているため、まだ解明されていません。COVID-19パンデミックの回復により、手術、治療、重篤な状況下で動物に提供される標準的ケアの一環として、動物用静注液の需要が増加しています。パンデミックの経済的影響は、ペットの飼い主や動物病院を含む多くの個人や企業に影響を与えました。経済的な制約がペットの飼い主の意思決定プロセスに影響を与えた可能性があり、輸液の使用を含む、必須ではない獣医学的処置や治療が減少した可能性があります。

さらに、北米では獣医学教育プログラムで輸液療法の重要性とさまざまな臨床状況での適切な使用が強調されているなど、さまざまな要因により、北米における動物用静注液の採用率は比較的高くなっています。獣医師および獣医療技術者は、輸液の投与、モニタリング、および管理について広範なトレーニングを受けており、輸液の適切な使用を実践しています。さらに、北米の獣医専門家は、動物に質の高いケアを提供しようと努力しています。輸液療法は、包括的な獣医学的治療の重要な要素であり、その採用は、患者ケアを最適化し、動物の回復と健康をサポートするというコミットメントによって推進されています。

動物用静注液市場レポートハイライト

  • 製品別では、等張晶析液セグメントが2022年に42%以上のシェアを占め、市場を独占しました。動物の水分補給と電解質バランスを回復・維持するため、動物医療における輸液療法では等張晶質液が頻繁に使用されます。
  • 動物タイプ別では、コンパニオンアニマルセグメンテーションが2022年の市場を独占しました。多くの家庭でコンパニオンアニマル、特に犬や猫がペットとして定期的に飼われています。ペットの飼育は、動物用静注液の大きな需要につながります。これらの動物は、さまざまな健康問題、手術、または重篤な治療状況のために点滴療法を頻繁に必要とするからです。
  • 適応症別では、糖尿病性ケトアシドーシス（DKA）セグメントが2022年の市場を独占しました。
  • 最終用途別では、ペットを動物病院に連れて行く人が増えていることから、動物病院セグメントが2022年の収益シェア55％以上で市場を独占しました。静脈内水分補給療法は、患者ケアの重要な一部として動物病院で頻繁に使用されています。
  • 北米は、2022年に市場の38.0%超という最も高い売上シェアを占めました。北米ではペットの飼育率が高く、多くの家庭で犬、猫、小型哺乳類などのコンパニオンアニマルが飼育されています。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報調達
  • 情報またはデータ分析
  • 市場の形成と検証
  • モデル詳細
  • データソースのリスト

第2章 エグゼクティブサマリー

第3章 動物用静注液市場の変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題の分析
  • 動物用静注液市場分析ツール
    • 業界分析- ポーター
    • PESTEL分析
    • 価格分析
    • 主要国別の推定動物個体数、2018年から2022年
    • COVID-19感染症の影響分析

第4章 動物用静注液市場：製品の推定・動向分析

  • セグメントダッシュボード
  • 動物用静注液市場：製品の変動分析と市場シェア、2022年および2030年
  • 等張晶質液
  • 合成コロイド
  • 血液製剤
  • ブドウ糖液
  • 非経口栄養

第5章 動物用静注液市場：適応症の推定と推定・動向分析

  • セグメントダッシュボード
  • 動物用静注液市場：適応症の変動分析と市場シェア、2022年および2030年
  • 糖尿病性ケトアシドーシス
  • 膵炎
  • 炭疽菌
  • 慢性腎臓病
  • その他

第6章 動物用静注液市場：動物タイプの推定・動向分析

  • セグメントダッシュボード
  • 動物用静注液市場：動物タイプの変動分析と市場シェア、2022年および2030年
  • コンパニオンアニマル
  • 生産動物

第7章 動物用静注液市場：最終用途の推定・動向分析

  • セグメントダッシュボード
  • 動物用静注液市場：最終用途の変動分析と市場シェア、2022年および2030年
  • 動物病院
  • 研究機関
  • その他

第8章 動物用静注液市場：地域の推定・動向分析

  • 地域の展望
  • 動物用静注液市場：地域の変動分析と市場シェア、2022年および2030年
  • 北米
    • SWOT分析
    • 北米の動物用静注液市場推計・予測、2018年から2030年
    • 米国
    • カナダ
  • 欧州
    • SWOT分析
    • 欧州の動物用静注液市場推計・予測、2018年から2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • SWOT分析
    • アジア太平洋地域の動物用静注液市場推計・予測、2018年から2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • SWOT分析
    • ラテンアメリカの動物用静注液市場推計・予測、2018年から2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • SWOT分析
    • 中東・アフリカの動物用静注液市場推計・予測、2018年から2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 主要な企業プロファイル
    • Participant's Overview
    • Product Benchmarking
    • Financial Performance
    • Strategic Initiatives
  • 参入企業
  • ヒートマップ分析/企業の市況分析
  • 戦略マッピング
  • 他の主要な市場プレーヤーのリスト
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Global Veterinary Intravenous Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Global Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 6 Global Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 10 North America Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 11 North America Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 14 U.S. Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 19 Canada Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 23 Europe Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 UK Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 27 UK Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 28 UK Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 31 Germany Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 32 Germany Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 France Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 34 France Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 35 France Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 36 France Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Italy Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 39 Italy Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 40 Italy Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Spain Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 43 Spain Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 44 Spain Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Denmark Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 47 Denmark Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 51 Sweden Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 52 Sweden Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Norway Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 54 Norway Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 55 Norway Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 56 Norway Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Japan Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 63 Japan Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 64 Japan Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 65 Japan Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 China Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 67 China Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 68 China Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 69 China Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 India Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 71 India Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 72 India Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 73 India Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 South Korea Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 75 South Korea Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 76 South Korea Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 77 South Korea Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Australia Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 80 Australia Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 81 Australia Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Thailand Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 84 Thailand Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 85 Thailand Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Latin America Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 88 Latin America Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 89 Latin America Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 90 Latin America Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Brazil Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 92 Brazil Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 93 Brazil Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 94 Brazil Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Mexico Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 96 Mexico Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 97 Mexico Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 98 Mexico Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 101 Argentina Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 102 Argentina Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA Veterinary Intravenous Solutions market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 106 MEA Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 107 MEA Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 110 South Africa Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 118 UAE Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 119 UAE Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Veterinary Intravenous Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Veterinary Intravenous Solutions market, by indication, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Veterinary Intravenous Solutions market, by animal type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Veterinary Intravenous Solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 124 Participant's overview
  • Table 125 Financial performance
  • Table 126 Product benchmarking
  • Table 127 Strategic Initiative

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Veterinary Intravenous Solutions market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 Veterinary Intravenous Solutions market snapshot
  • Fig. 11 Veterinary Intravenous Solutions market driver impact
  • Fig. 12 Veterinary Intravenous Solutions market restraint impact
  • Fig. 13 Porter's 5 Forces Analysis
  • Fig. 14 PESTEL Analysis
  • Fig. 15 Veterinary Intravenous Solutions market product key takeaways (USD Million)
  • Fig. 16 Veterinary Intravenous Solutions market: product movement analysis
  • Fig. 17 Global Isotonic crystalloids market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Synthetic colloids market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Blood products market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Dextrose solutions market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Parenteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 22 Veterinary Intravenous Solutions indication key takeaways (USD Million)
  • Fig. 23 Veterinary Intravenous Solutions market: Indication movement analysis
  • Fig. 24 Global Diabetic Ketoacidosis market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Pancreatitis Market, 2018 - 2030 (USD Million)
  • Fig. 26 Global Anthrax market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Chronic Kidney Disease Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Others market, 2018 - 2030 (USD Million)
  • Fig. 29 Veterinary Intravenous Solutions market animal type key takeaways (USD Million)
  • Fig. 30 Veterinary Intravenous Solutions market: Animal type movement analysis
  • Fig. 31 Global companion animals market, 2018 - 2030 (USD Million)
  • Fig. 32 Global production animals market, 2018 - 2030 (USD Million)
  • Fig. 33 Veterinary Intravenous Solutions market end-use key takeaways (USD Million)
  • Fig. 34 Veterinary Intravenous Solutions market: end-use movement analysis
  • Fig. 35 Global veterinary hospitals market, 2018 - 2030 (USD Million)
  • Fig. 36 Global research institutes market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Others market, 2018 - 2030 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Regional outlook, 2022 & 2030
  • Fig. 40 North America Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 44 UK Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 46 France Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 54 China Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 55 India Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait Veterinary Intravenous Solutions market, 2018 - 2030 (USD Million)
  • Fig. 68 Market participant categorization
  • Fig. 69 Heat map analysis/Company market position analysis
目次
Product Code: GVR-4-68040-099-7

Veterinary Intravenous Solutions Market Growth & Trends

The global veterinary intravenous solutions market size is expected to reach USD 2.67 billion by 2030, expanding at a CAGR of 8.37% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth is driven by increasing awareness of animal welfare, advancements in veterinary healthcare, increasing pet ownership, and the increasing prevalence of illnesses such as anthrax, pancreatitis, and mouth disease. The advancements in veterinary medicine have expanded the range of treatment options available for animals. Veterinary clinics and hospitals are equipped with advanced diagnostic and treatment facilities, including intravenous fluid administration systems, which contribute to the growth of the market.

The development of advanced IV fluid delivery systems designed specifically for veterinary use has made the administration process more efficient, accurate, and safe. These technological advancements, such as specialized infusion pumps and fluid monitoring systems, have positively impacted the veterinary intravenous solutions industry by enhancing patient care and reducing the risk of complications. Rising disposable income levels in many regions have led to increased spending on pet healthcare. Pet owners are more willing to invest in high-quality veterinary care, including intravenous fluid therapy, which contributes to the growth of the market.

The post-COVID-19 impact on the veterinary intravenous solutions industry is still unfolding as the global situation continues to evolve. The COVID-19 pandemic recovery has led to an increased demand for veterinary intravenous solutions as part of the standard care provided to animals during surgeries, treatments, and critical care situations. The economic impact of the pandemic affected many individuals and businesses, including pet owners and veterinary clinics. Financial constraints may have influenced the decision-making process for pet owners, potentially leading to a decrease in non-essential veterinary procedures and treatments, including the use of IV fluids.

Moreover, the adoption of veterinary intravenous (IV) fluid solutions in North America is relatively high due to various factors such as veterinary education programs in North America emphasizing the importance of IV fluid therapy and its appropriate use in different clinical situations. Veterinarians and veterinary technicians receive extensive training in the administration, monitoring, and management of IV fluids, ensuring their competent use in practice. Furthermore, veterinary professionals in North America strive to provide high-quality care for animals. IV fluid therapy is a crucial component of comprehensive veterinary treatment, and its adoption is driven by the commitment to optimize patient care and support the recovery and well-being of animals.

Veterinary Intravenous Solutions Market Report Highlights

  • Based on product, the isotonic crystalloids segment dominated the market with a share of over 42% in 2022. To restore and maintain hydration and electrolyte balance in animals, fluid therapy in veterinary medicine frequently uses isotonic crystalloid solutions
  • Based on animal type, the companion animals segment dominated the market in 2022. Many homes regularly keep companion animals as pets, especially dogs and cats. Pet ownership leads to a large demand for veterinary intravenous solutions, as these animals frequently require intravenous therapy for a variety of health issues, surgeries, or critical care situations
  • Based on indication, the Diabetic Ketoacidosis (DKA) segment dominated the market in 2022
  • Based on end-use, the veterinary hospital segment dominated the market with a revenue share of over 55% in 2022, as more people are taking their pets to veterinarian facilities for care. IV hydration therapy is frequently used in veterinary hospitals as a crucial part of patient care
  • North America held the highest revenue share of over 38.0% of the market in 2022. In North America, there is a high rate of pet ownership, with many homes keeping companion animals like dogs, cats, and small mammals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Intravenous Solutions Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for companion animals and pets
      • 3.2.1.2. Increasing prevalence of illnesses such as anthrax, pancreatitis, mouth disease
      • 3.2.1.3. Increase in the need for nutrition-rich food, focus on food safety, and increasing care for animals
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of awareness regarding the use of veterinary intravenous solutions
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Intravenous Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
    • 3.3.3. Pricing Analysis
    • 3.3.4. Estimated Animal Population, by key countries, 2018 to 2022
    • 3.3.5. COVID-19 Impact Analysis

Chapter 4. Veterinary Intravenous Solutions Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Intravenous Solutions Market: Product Movement Analysis & Market Share, 2022 & 2030
  • 4.3. Isotonic crystalloids
    • 4.3.1. Isotonic Crystalloids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Synthetic colloids
    • 4.4.1. Synthetic Colloids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Blood products
    • 4.5.1. Blood Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Dextrose solutions
    • 4.6.1. Dextrose Solutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Parenteral nutrition
    • 4.7.1. Parenteral Nutrition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Intravenous Solutions Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Intravenous Solutions Market: Indication Movement Analysis & Market Share, 2022 & 2030
  • 5.3. Diabetic Ketoacidosis
    • 5.3.1. Diabetic Ketoacidosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pancreatitis
    • 5.4.1. Pancreatitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Anthrax
    • 5.5.1. Anthrax Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Chronic Kidney Disease
    • 5.6.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Intravenous Solutions Market: Animal Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Intravenous Solutions Market: Animal Type Movement Analysis & Market Share, 2022 & 2030
  • 6.3. Companion Animals
    • 6.3.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Production Animals
    • 6.4.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Intravenous Solutions Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Intravenous Solutions Market: End-Use Movement Analysis & Market Share, 2022 & 2030
  • 7.3. Veterinary Hospitals
    • 7.3.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Research Institutes
    • 7.4.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Intravenous Solutions Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Veterinary Intravenous Solutions Market: Regional Movement Analysis & Market Share, 2022 & 2030
  • 8.3. North America
    • 8.3.1. SWOT Analysis
    • 8.3.2. North America Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. The U.S.
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Regulatory Framework
      • 8.3.3.3. U.S. Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Canada
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Regulatory Framework
      • 8.3.4.3. Canada Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. SWOT Analysis
    • 8.4.2. Europe Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. UK Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Germany
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Germany Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. France
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Regulatory Framework
      • 8.4.5.3. France Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Italy
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Regulatory Framework
      • 8.4.6.3. Italy Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Spain
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Regulatory Framework
      • 8.4.7.3. Spain Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Regulatory Framework
      • 8.4.8.3. Denmark Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Sweden
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Regulatory Framework
      • 8.4.9.3. Sweden Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.10. Norway
      • 8.4.10.1. Key Country Dynamics
      • 8.4.10.2. Regulatory Framework
      • 8.4.10.3. Norway Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. SWOT Analysis
    • 8.5.2. Asia Pacific Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Japan Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. China
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. China Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. India
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. India Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. South Korea Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Australia Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Thailand
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Thailand Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. SWOT Analysis
    • 8.6.2. Latin America Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Brazil
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Brazil Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Mexico
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Mexico Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Argentina
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Argentina Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. SWOT Analysis
    • 8.7.2. Middle East & Africa Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. South Africa
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. South Africa Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Regulatory Framework
      • 8.7.4.3. Saudi Arabia Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. UAE
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Regulatory Framework
      • 8.7.5.3. UAE Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.6. Kuwait
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Regulatory Framework
      • 8.7.6.3. Kuwait Veterinary Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Key Company Profiles
    • 9.1.1. Participant's Overview
    • 9.1.2. Product Benchmarking
    • 9.1.3. Financial Performance
    • 9.1.4. Strategic Initiatives
      • 9.1.4.1. Merck & Co., Inc.
      • 9.1.4.2. Dechra Veterinary Products
      • 9.1.4.3. Sypharma
      • 9.1.4.4. Animalcare
      • 9.1.4.5. B. Braun SE
      • 9.1.4.6. Woods Consulting, LLC
      • 9.1.4.7. Baxter
      • 9.1.4.8. Fresenius Kabi
  • 9.2. Participant Categorization
  • 9.3. Heat Map Analysis/ Company Market Position Analysis
  • 9.4. Strategy Mapping
  • 9.5. List of Other Key Market Players